Full-Time

Vice President

Growth, Clinical Trial Optimization

Posted on 12/20/2024

Iterative Health

Iterative Health

51-200 employees

AI-driven solutions for gastrointestinal care

AI & Machine Learning
Healthcare

Expert

Cambridge, MA, USA + 1 more

More locations: New York, NY, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • 10+ years of experience in clinical research, healthcare, or related industries, with a focus on growth and business development
  • Proven track record of scaling networks or organizations through organic and inorganic means
  • Strong understanding of clinical trial site operations, regulatory requirements, and industry dynamics
  • Experience in developing and implementing scalable operational frameworks or playbooks
  • Excellent strategic thinking, negotiation, and relationship-building skills
  • Exceptional leadership abilities, with a track record of inspiring and managing teams
  • Familiarity with clinical trial processes, site management practices, and compliance requirements within the healthcare industry
  • MBA, MPH, or relevant advanced degree
Responsibilities
  • Own expansion of IH research site footprint in US and ex-US – this will include:
  • Organic Growth:
  • Identify, cultivate, and onboard high-quality research sites to expand the network.
  • Define business case, pitch, and business model for all prospective partners
  • Build relationships with key stakeholders, including site investigators and administrators, to strengthen and deepen partnerships
  • Inorganic Growth:
  • Lead efforts to identify and evaluate potential acquisitions of research sites / site networks
  • Define framework to evaluate which sites are appropriate for an inorganic vs. organic growth approach and refine scope of business models
  • Collaborate with VP of Corp Dev to pitch acquisitions and get sites onboard
  • Own strategy to expand research footprint by identifying and launching the development of research naive sites
  • Identify pipeline of research naive sites within our existing site footprint and beyond
  • Determine appropriate business model for research naive sites
  • Collaborate with cross functional teams to build operational plan to launch research naive sites
  • Establish metrics for assessing the success and scalability of newly created sites
  • Leadership and collaboration
  • Partner with executive team to align network growth strategy with overall Clinical Trial Optimization (CTO) business objectives
  • Represent the company at industry events, conferences, and meetings with prospective partners

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve patient outcomes globally.

Company Stage

Series B

Total Funding

$182.1M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-16%

2 year growth

-24%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven predictive analytics in gastroenterology allow for personalized, effective patient care.
  • Integration of AI in endoscopy improves detection rates, enhancing SKOUT® device effectiveness.
  • AI-based recruitment tools increase efficiency and success rates of IBD clinical trials.

What critics are saying

  • Competition from tech giants in AI medical imaging threatens Iterative Health's market share.
  • Rapid expansion and partnerships may strain Iterative Health's operational capabilities and resources.
  • Reliance on AI exposes Iterative Health to potential biases, affecting diagnosis accuracy and trust.

What makes Iterative Health unique

  • Iterative Health uses AI to enhance GI care, focusing on colorectal cancer prevention.
  • Their SKOUT® device is FDA cleared for adenoma detection, aiding in accurate diagnoses.
  • AI-enabled documentation technology optimizes clinical trials, improving patient care quality and continuity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off